Associate, Global Scientific Communications (GSC), Document Delivery at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Correct errors in grammar, style, formatting, and syntax; identify and fix flaws in logic and flow
  • Follow style guides/templates provided by the team and Lilly internal standards
  • Verify data against source files, ensure accuracy and consistency of data and content within and between related documents
  • Collaborate with global counterparts and track document metrics across groups
  • Produce final eCTD-compliant PDFs using publishing software; review and format Word files for compliance; render to PDFs and edit as needed
  • Provide editorial and project management support, including formatting, proofreading, rendering, bookmarking
  • Conduct literature searches; obtain and process copyright transfer and authorship agreements
  • Verify data and references for accuracy; create figures and diagrams
  • Write cover letters to journal editors; coordinate translation and/or validation
  • Handle systems of record (e.g., DataVision, RIM, Planisware Book of Work) with data steward/project management responsibilities
  • Support encoring efforts across therapy areas, functions, and regions by editing, adapting word counts, and completing publication procedures
  • Coordinate workload and work assignments with DDH Air Traffic Control direction locally and globally

Responsibilities

  • Ensure timely delivery of error-free, high-quality documents that meet international standards of written English
  • Provide leadership, internal coordination, and guidance as a member of the GSC Document Delivery Hub (DDH)
  • Partner across Global Scientific Communications (GSC) and key partners to ensure documents meet all guidelines, Lilly policies, and external requirements
  • Participate in producing electronically compliant documents for regulatory submissions (e.g., FDA/EMA) and publication deliverables (manuscripts, posters/presentations)
  • Work with writing teams to establish and supervise key milestone timelines
  • Edit documents for style/usage and content
  • Ensure all steps of the submission process are driven
  • Achieve time-bound deliverables (as described in the truncated description)

Skills

Scientific Communications
Document Delivery
Grammar Correction
Style Editing
Formatting
Syntax Correction
Regulatory Submissions
FDA Compliance
EMA Compliance
Manuscript Preparation
Poster Design
Presentation Development

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI